GPTHEALTH161.06

GPT Healthcare Limited

· Pharma & Health
₹ CrorePeersGKSLSHALBYINDRAMEDCOLOTUSEYEARTEMISMEDDRAGARWQKMCSHILKOVAIMcap ₹1,322 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Returns
Return on Common Equity21.8620.1415.6715.67
Return on Assets13.8312.999.089.08
Return on Capital Employed26.0420.7514.8214.82
Return on Invested Capital22.4920.3518.4520.59
Margins
EBITDA Margin21.9520.4817.8118.51
Operating Margin17.4615.8012.0812.08
Incremental Operating Margin-80.22-11.04
Pretax Margin17.0017.0311.6012.38
Net Income Margin11.9412.268.939.61
FCF Margin12.354.298.338.33
Additional
Effective Tax Rate29.8028.0122.9622.33
Dvd Payout Ratio50.1857.5348.59
Sustainable Growth Rate10.898.558.0615.67
Incremental Operating Margin %-80.22-11.0432.04
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.